Santander’s newly-spun out venture capital arm Mouro Capital has joined the investor consortium of Europe-focused startup loans provider Uncapped.
Month: September 2020
Siolta surges to $30m series B
Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.
ETS starts corporate venturing
The nonprofit educational organisation’s ETS Strategic Capital unit will invest in edtech companies at early to late-stage, having already made five deals.
Willow pumps $55m round
Willow, which markets discreet breastfeeding pump technology, reportedly counts Johnson & Johnson Innovation – JJDC as an investor.
MadaLuxe agrees first deal with Psykhe
Sandy Sholl, the co-founder and chairwoman of MadaLuxe, is head of SLS Journey as its new corporate venturing unit.
Necessity is the mother of invention
There are some useful lessons when looking at climate change and limiting or reversing carbon dioxide in the atmosphere to look back at the first global initiative to tackle similar concerns over the ozone layer holes caused by CFCs.
Beyond Limits lines up $133m series C
Group 42 has joined existing shareholder BP Ventures to co-lead a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed and another $20m committed.
Wanwu Xinsheng upgrades to $100m series E-plus
Formerly known as Aihuishou, the electronics recycler has attracted more than $100m in series E-plus funding co-led by existing shareholder JD.com.
Nucarf embraces $100m across two rounds
Nucarf has procured approximately $100m in combined series A and A-plus funding, with the former round featuring Xiamen C&D.
Swire Pacific helps plant $70m in Green Monday
Green Monday is working on a plant-based alternative to pork and has raised the money from investors including Swire Pacific and returning backer Lee Kum Kee Health Products.
Pureos Bioventures closes $170m fund
Pureos Bioventures has backed five spinouts so far from its multi-corporate-backed, biotech-focused fund.
Virogin Biotech transmits $62m series C
Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.
Outschool passes $45m series B test
Sesame Workshop’s online education portfolio company has raised fresh funding to seize on higher demand during the coronavirus pandemic.
Carlyle Group to screen TriNetX for acquisition
TriNetX had raised $102m in funding from investors including Merck & Co, Mitsui and Itochu before agreeing to a purchase by Carlyle.